Skip to main content

Advertisement

Log in

Vogt–Koyanagi–Harada disease occurring during interferon-alpha and ribavirin therapy for chronic hepatitis C virus infection

  • Case Report
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

We report a case of Vogt–Koyanagi–Harada (VKH) disease in a 30-year-old patient who was receiving interferon-alpha and ribavirin therapy for chronic hepatitis C virus infection. The intraocular inflammation responded to systemic corticosteroid and mycophenolate mofetil treatment. Physicians should be aware of the association between interferon-alpha and ribavirin therapy for hepatitis C virus infection and the development of VKH disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. Moorthy RS, Inomata H, Rao NA (1995) Vogt–Koyanagi–Harada syndrome. Surv Ophthalmol 39:265–292

    Article  CAS  PubMed  Google Scholar 

  2. Yamaki K, Kondo I, Nakamura H et al (2000) Ocular and extraocular inflammation induced by immunization of tyrosinase related protein 1 and 2 in Lewis Rats. Exp Eye Res 71:361–369

    Article  CAS  PubMed  Google Scholar 

  3. Kawano T, Shigehira M, Uto H et al (1996) Retinal complications during interferon therapy for chronic hepatitis C. Am J Gastroenterol 91:309–313

    CAS  PubMed  Google Scholar 

  4. Kasahara A, Hiraide A, Tomita N et al (2004) Vogt–Koyanagi–Harada disease occurring during interferon alpha therapy for chronic hepatitis C. J Gastroenterol 39:1106–1109

    Article  PubMed  Google Scholar 

  5. Sène D, Touitou V, Bodaghi B et al (2007) Intraocular complications of IFN-alpha and ribavirin therapy in patients with chronic viral hepatitis C. World J Gastroenterol 13:3137–3140

    PubMed  Google Scholar 

  6. Sylvestre DL, Disston AR, Bui DP (2003) Vogt–Koyanagi–Harada disease associated with interferon alpha-2b/ribavirin combination therapy. J Viral Hepat 10:467–470

    Article  CAS  PubMed  Google Scholar 

  7. Papastathopoulos K, Bouzas E, Naoum G et al (2006) Vogt–Koyanagi–Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection. J Infect 52:e59–e61

    Article  PubMed  Google Scholar 

  8. Touitou V, Bodaghi B, Cassoux N et al (2005) Vogt–Koyanagi–Harada disease in patients with chronic hepatitis C. Am J Ophthalmol 140:949–952

    Article  PubMed  Google Scholar 

  9. Touitou V, Sene D, Fardeau C et al (2007) Interferon-alpha2a and Vogt–Koyanagi–Harada disease: a double-edged sword? Int Ophthalmol 27:211–215

    Article  PubMed  Google Scholar 

  10. Pellicano R, Smedile A, Peyre S et al (2005) Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist’s view. Minerva Gastroenterol Dietol 51:55–61

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Ms. Connie B. Unisa-Marfil for secretarial work. This work was supported by Medical Research Chair funded by Dr. Nasser Al-Rasheed.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ahmed M. Abu El-Asrar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Al-Muammar, A.M., Al-Mudhaiyan, T.M., Al Otaibi, M. et al. Vogt–Koyanagi–Harada disease occurring during interferon-alpha and ribavirin therapy for chronic hepatitis C virus infection. Int Ophthalmol 30, 611–613 (2010). https://doi.org/10.1007/s10792-010-9357-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-010-9357-0

Keywords

Navigation